Navigation Links
Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
Date:10/15/2008

their service providers, supports clinical trials of all sizes, from single site studies to multi-national programs. The TrialWorks solution provides comprehensive trial management data for the entire clinical team, from consolidated metrics for senior management to reports for project teams. It delivers relevant information to all study stakeholders, promotes operational and workflow standards, and helps to ensure timely investigator payments as well as accurate financial reporting. The system also provides online and offline access to clinical monitors.

New enhancements to the TrialWorks solution include:

-- "My Reports" - with over 175 standard reports tailored for key departments and an ad-hoc reporting component, this feature now allows users and project teams to more easily access and share frequently used reports, saving time and creating a more organized reporting environment

-- Compatibility with new requirements of the ClinicalTrials.gov website, and ability to export files for import into ClinicalTrials.gov

-- New options to classify studies, offering greater flexibility in grouping studies together, as well as enhancements for more detailed filtering and analysis of study information

Additionally, a new web interface for the Universal Data Transfer Tool, which can be used in conjunction with the TrialWorks solution, provides a more streamlined transfer of patient and visit data as well as Case Report Form (CRF) status from other systems.

The TrialWorks solution, previously part of the ClinPhone product portfolio, has been used for thousands of clinical trials. The system, which has a user-friendly and intuitive interface, can be rapidly implemented company-wide. The TrialWorks solution can be licensed and installed, or implemented as a hosted solution.

About Perceptive Informatics

Perceptive Informatics, a subsidiary of PAREXEL, is one of the industry's leading eClinical technology providers. Percep
'/>"/>

SOURCE PAREXEL International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
2. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
3. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
4. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
5. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Tailored Clopidogrel Dosing Improves PCI Outcomes
8. Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
9. SuperGens DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine
10. Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
11. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...cal Incorporated (Nasdaq: VICL ) announced today...rom Merck & Co., Inc. based on Merck,s planned...stigational plasmid DNA (pDNA) cancer vaccine. The...livery technology and encodes human telomerase rev...f separate license agreement. , , "The brea...
(Date:11/28/2008)...- Eli Lilly and Company,(NYSE: LLY ) has withdr...rom,the U.S. Food and Drug Administration (FDA) f...t of chronic pain. Lilly plans to resubmit the app...rom a recently completed positive study,in chroni...cision does not affect duloxetine,s FDA-approved i...
(Date:11/26/2008)...KLIN, Mass., Nov. 26 PLC...d today that it has received full approval from th...U.S. pivotal trial to study the effectiveness of t... therapy in the prevention of Contrast-Induced Nep...LC,s request to expand their investigation from th...
(Date:11/25/2008)...re/ -- Proteolix, Inc., a,leader in the discovery...,protein degradation pathways in cancer and autoi...o ongoing Phase 2 clinical trials of carfilzomib i...ing 50th Annual Meeting of the,American Society o... new class,of specific proteasome inhibitors and ...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3LI COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging 8527 1LI COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging 8527 2DFG continues to strengthen biodiversity research 5543 1DFG continues to strengthen biodiversity research 5543 2Innovative strategies for war wounded 5538 1Innovative strategies for war wounded 5538 2Field hospital on a chip project awarded to nanoengineer from UC San Diego 5536 1Field hospital on a chip project awarded to nanoengineer from UC San Diego 5536 2Field hospital on a chip project awarded to nanoengineer from UC San Diego 5536 3
...lso Support Drug,s Efficacy at Improving Glycemic ...ications, CHICAGO, Ill., June 23, 2007 /PRNewswire...mercialization partner S2 Therapeutics,Inc., repo...trial,supporting the overall and cardiovascular sa...of bromocriptine mesylate) in subjects,with type 2...
...R CITY, Calif.--(BUSINESS WIRE)--June 25, 2007--Gi...that Study 103, a,Phase III clinical trial evaluat...R) (tenofovir disoproxil fumarate or tenofovir,DF)...itis B virus,(HBV) infection, met its primary effi...ferior to the company,s once-daily antiviral,drug ...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
(Date:12/1/2008)... Dec. 1 Actavis Group, the interna...unced that it has received approval from the U.S. ... Hydrochloride extended-release tablets (XL) 150mg... , Bupropion Hydrochloride extended-release ...h, are the generic equivalent of Wellbutrin XL(R) ...
(Date:12/1/2008)... , Ideas from U-M physician include economical... A bottle of cologne, a... and easy gifts to buy and wrap for the upcoming h...ng more healthy and beneficial to a loved one? Why...healthy around the holidays can be challenging, an...
(Date:12/1/2008)...PRNewswire/ -- Resurrection Health Care has been r...lthcare by Modern Healthcare,magazine. The nation...ing,homes, retirement communities, home health se...ices throughout the Chicago area. , Modern ...s health care,organizations nationwide that enabl...
(Date:12/1/2008)... 1 Prior generations often shared,...ents -- typically because,seniors didn,t live far...h,life expectancy having increased by an average ...mbered by health care concerns, which may make old...emselves. In the recently published,Evercare(R) S...
Breaking Medicine News(10 mins):Health News:Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S. 2Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:Resurrection Health Care Named One of Nation's 'Best Places to Work in Healthcare' 2Health News:Take Time to Care for the Caregiver 2
... the brain of youngsters, says a study, which stre... can do to them. // Thomas Heffernan, a psychologi...llege students for the research presented at the B...s annual conference in York, reported the online e...
...r still remains the best way to ensure patient s...ring the 85th General Session of the International...the University of California-Irvine presented two ...approaches to oral cancer detection, diagnostic sc...
...m Aberdeen University are on the brink of another ...s of lives,// by an early diagnosis of cancer, Alz...ther disorders. A prototype of an MRI scanner has...ferent images, compared to one image from current ...
...oon urged governments to join the anti-tuberculosi...n coming years as// the disease has become extreme...ng the importance of World TB Day on Saturday. The...tly reported about the rise in the extensively dru...
Other Medicine News:Health News:Novel Methods in Diagnosing Oral Cancer 2Health News:Breakthrough in MRI Scanning in the Near Future 2
15" overall length, 9" handle.
Gimmi Yasargil Aneurysm-Vessel-Clips
Yasargil Phynox Aneurysm Clips Standard
EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in
Medicine Products: